United Kingdom · Who invested in Heptares Therapeutics?
Heptares Therapeutics's investors include Clarus Ventures, MVM Life Science Partners, Takeda Ventures and Stanley Family Foundation.
2009201120132015
?Seed$21MSeries B$5.5MGrant
United Kingdom · Funded startup
Who invested in Heptares Therapeutics
Funding summaryUpdated 26 Oct 2026
$27Mraised across 3 rounds since 2007, from 3 sources
$21MSeries B$5.5MGrant
- Latest round
- Grant, $5.5MSept 2015
- Biggest round
- $21MSeries B · Jun 2013
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed Aug 2007
- Biggest round
- $21M Series B · Jun 2013
- Usual gap between rounds
- 5.9 years the median of 2
The rounds
- Sept 2015Grant$5.5M
No investor was named in the report.
From a historical funding record
- Jun 2013
- Aug 2007
Founders and team
From Heptares Therapeutics's own website: 11 on the team.
- Mr. Chris CargillPresident and Chief Executive Officer
- Mr. Hironoshin NomuraChief Financial Officer
- Mr. Kieran JohnsonChief Accounting Officer
- Ms. Candelle ChongChief of Staff
- Ms. Mariko NakafujiChief Legal Officer
- Dr. David RoblinExternal Independent Director
- Dr. Takeo MorookaExternal Independent Director
- Mr. Rolf SoderstromExternal Independent Director
- Mrs. Eiko TomitaExternal Independent Director
- Ms. Naoko ShimuraExternal Director
- Ms. Nicola RabsonExternal Independent Director
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Seed2007Series B2013Grant2015
Clarus Ventures
MVM Life Science PartnersTakeda Ventures
Stanley Family Foundation
Clarus VenturesMVM Life Science PartnersTakeda VenturesStanley Family FoundationThe exit
ExitBuyerPriceWhen
AcquiredSoseiundisclosedFeb 2015
From historical deal records. Wrong? Tell us.
Everyone who backed them
Takeda VenturesCorporate VC1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Heptares Therapeutics
How much has Heptares Therapeutics raised?
Heptares Therapeutics has raised $27M across 3 rounds since 2007. One round did not disclose an amount, so the total is a floor.
When did Heptares Therapeutics last raise?
Heptares Therapeutics's most recent round was a Grant of $5.5M in Sept 2015.
What was Heptares Therapeutics's biggest round?
Heptares Therapeutics's largest round on record is $21M (Series B), in Jun 2013.
Who backed Heptares Therapeutics first?
Heptares Therapeutics's first round on record, in Aug 2007, was backed by MVM Life Science Partners.
What stage is Heptares Therapeutics at?
Heptares Therapeutics's latest named round is a Grant, in Sept 2015.
Where is Heptares Therapeutics based?
Heptares Therapeutics is based in the United Kingdom.
Companies like Heptares Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.